Search

Compugen Ltd

Uždarymo kaina

2.39 4.37

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.29

Max

2.42

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-65M

-7.7M

Pardavimai

-65M

2.2M

P/E

Sektoriaus vid.

6.263

68.51

Pelnas, tenkantis vienai akcijai

-0.07

Pelno marža

-352.436

Darbuotojai

75

EBITDA

-64M

-7.7M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+117.39% upside

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-45M

225M

Ankstesnė atidarymo kaina

-1.98

Ankstesnė uždarymo kaina

2.39

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-07 23:56; UTC

Correlated Moves

American Water Works shows little change in after-market trading, remaining near the upper end of its one-month range amid reduced rate hike concerns.

2026-08-07 23:56; UTC

Lululemon Athletica shares are higher in after-market hours, continuing a trend of four consecutive sessions above the 20-day moving average. No specific news was identified.

2026-08-07 23:56; UTC

Crown Holdings Inc shares are lower in after-market hours, continuing a downward trend amid decreased expectations for immediate Federal Reserve interest rate hikes.

2026-08-07 23:56; UTC

Arcosa Inc shares declined slightly in after-market trading, remaining near the lower end of their one-month trading range. No specific news was identified.

2026-08-07 23:56; UTC

No specific news for Synchrony Financial as after-market trading remains roughly flat. The stock is above its 20-day moving average and near its one-month high.

2026-08-07 23:56; UTC

Correlated Moves

Insteel Industries Inc. shares remained roughly flat in after-market hours, reflecting broader market dynamics and the impact of Federal Reserve interest rate considerations.

2026-08-07 23:56; UTC

Atkore Inc. shares declined after-market, retracing from an initial peak post-close. The stock remains near the upper end of its one-month range.

2026-08-07 23:56; UTC

Academy Sports and Outdoors Inc. shares are roughly flat in after-market trading, with no specific news driving the minimal movement since Friday's close.

2026-08-07 23:56; UTC

Correlated Moves

Snap-On Inc shares are higher in after-market trading, reflecting strong interest and aligning with broader market trends. The stock remains above its 20-day moving average.

2026-08-07 23:56; UTC

Correlated Moves

Waters Corp shares declined in after-market trading, following a broader trend influenced by recent economic data and a weak jobs report.

2026-08-07 23:56; UTC

Cerus Corp shares are higher in after-market trading, recovering from earlier declines amid shifting expectations for Federal Reserve interest rate hikes.

2026-08-07 23:56; UTC

Marriott International shares are higher in after-market trading, though no specific news was identified to explain the movement. The stock remains below its 20-day moving average.

2026-08-07 23:56; UTC

Ensign Group Inc. shares traded roughly flat in after-market hours, reflecting minor adjustments amid Federal Reserve interest rate outlook concerns following a weak jobs report.

2026-08-07 23:56; UTC

Brady Corp shares are higher in after-market trading, reflecting a modest gain since Friday's close and positioning above its 20-day moving average.

2026-08-07 23:56; UTC

American States Water Co. shares traded roughly flat after hours amid broader market concerns about the Federal Reserve's interest rate policies following a weak jobs report.

2026-08-07 23:56; UTC

Axos Financial Inc. shares were roughly flat in after-market trading amid broader market concerns over potential Federal Reserve interest rate hikes.

2026-08-07 23:56; UTC

Toro Co shares traded with little change during after-market hours, fluctuating within a narrow range. The stock remains above its 20-day moving average.

2026-08-07 23:56; UTC

NAPCO Security Technologies traded roughly flat in after-market hours, remaining significantly above its 20-day moving average after seven consecutive sessions of higher closes.

2026-08-07 23:56; UTC

Bio Rad Laboratories Inc. shares declined in after-market trading, reflecting routine fluctuations. The stock remains above its 20-day moving average.

2026-08-07 23:56; UTC

ABM Industries shares showed routine trading activity after market hours, fluctuating slightly around Friday's close and remaining near the upper end of its one-month range.

2026-08-07 23:56; UTC

Equifax Inc. shares were roughly flat during after-market hours, trading near the upper end of their one-month range. No specific news was identified.

2026-08-07 23:56; UTC

Correlated Moves

Steven Madden Ltd traded roughly flat in after-market hours, reflecting broader market trends amid tempered expectations for Federal Reserve interest rate hikes.

2026-08-07 23:56; UTC

Prestige Consumer Healthcare Inc. shares traded roughly flat after-market hours, following six consecutive higher daily closes and remaining above its 20-day moving average.

2026-08-07 23:56; UTC

Shares of LTC Properties Inc. are higher in after-market hours, influenced by decreased expectations for immediate interest rate hikes following a weak jobs report.

2026-08-07 23:56; UTC

Correlated Moves

News Corp shares gained slightly in after-market trading, supported by a favorable market environment following a weak jobs report and decreased rate hike expectations.

2026-08-07 23:56; UTC

PJT Partners Inc shares are higher in after-market trading, despite no specific news. A weaker jobs report may be influencing investor sentiment.

2026-08-07 23:56; UTC

UDR Inc shares declined in after-market trading, reflecting broader market concerns over potential Federal Reserve interest rate hikes amid weak job data.

2026-08-07 23:56; UTC

Correlated Moves

Whirlpool Corp shares rose in after-market trading, reflecting broader market trends and decreased expectations for immediate interest rate hikes following a weak jobs report.

2026-08-07 23:56; UTC

Universal Health Services Inc. shares are lower in after-market trading, reflecting routine performance amid recent macroeconomic data and a weak jobs report.

2026-08-07 23:56; UTC

Correlated Moves

Albany International Corp shares are higher in after-market trading, supported by broader market dynamics and decreased interest rate hike expectations following a weak jobs report.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

117.39% į viršų

12 mėnesių prognozė

Vidutinis 5 USD  117.39%

Aukščiausias 6 USD

Žemiausias 4 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

3

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat